Marché mondial des vasodilatateurs – Tendances et prévisions de l'industrie jusqu'en 2030

Analyse et taille du marché des vasodilatateurs

Les vasodilatateurs sont un élément clé du traitement de l’hypertension (pression artérielle élevée). En relaxant et en élargissant les vaisseaux sanguins, les vasodilatateurs réduisent la résistance au flux sanguin, ce qui contribue à réduire la pression artérielle. L’hypertension est un facteur de risque courant et important de maladies cardiovasculaires, ce qui rend la gestion de la pression artérielle cruciale pour la santé publique.

Data Bridge Market Research analyse que le marché des vasodilatateurs, qui était de 6 300,00 millions USD en 2022, devrait atteindre 10 041,24 millions USD d'ici 2030 et devrait connaître un TCAC de 6,0 % au cours de la période de prévision 2023-2030. Les « dilatateurs artériels » dominent le segment type du marché des vasodilatateurs en raison de la prévalence croissante de l'hypertension. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché

Market Definition

Vasodilators encompass a wide range of drugs and compounds used to manage various cardiovascular and vascular conditions. The market's size is significant due to the prevalence of conditions such as hypertension, heart disease, and peripheral vascular diseases worldwide.

Vasodilators are the class of therapeutics that causes vasodilation which means widen the blood vessels so that blood flows more easily through the blood vessels. Vasodilators help in the treatment of cardiovascular disorders such as high blood pressure and congestive heart failure.  It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.

Global Vasodilators Market Dynamics

Drivers

• Rising Prevalence of Hypertension and Cardiovascular Diseases

Hypertension (high blood pressure) and cardiovascular diseases are among the leading causes of morbidity and mortality worldwide. Vasodilators are commonly used to manage these conditions by lowering blood pressure and improving blood flow. As these diseases continue to affect a significant portion of the global population, the demand for vasodilators remains high.

• Increased Awareness and Diagnosis

Increased awareness of cardiovascular risk factors and the importance of early diagnosis have led to more individuals seeking medical care and being diagnosed with hypertension and cardiovascular diseases. As a result, more patients are prescribed vasodilators, driving market growth.

Opportunity

• Government Initiatives and Healthcare Policies

Government healthcare policies and initiatives aimed at reducing the burden of cardiovascular diseases and improving public health may involve subsidies, funding for research, and support for the use of vasodilators. These policies can boost the market.

Restraints/Challenges

• Complex Treatment Regimens

Vasodilators are often used in combination with other medications, such as diuretics and beta-blockers, to optimize treatment. Complex treatment regimens can be challenging for patients to follow, leading to difficulties in medication adherence.

Recent Development

• In December 2021, Bayer AG announced that the company had received a product designation from the FDA (Food and Drug Administration) for artificial intelligence technology for Chronic Thromboembolic Pulmonary Hypertension (CTPH) Pattern Recognition.

Global Vasodilators Market Scope

The Vasodilators market is segmented on the basis of type, drugs, indication, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Arterial Dilators
• Venous Dilators
• Mixed Dilators

Drugs

• Nitroglycerin
• Alprostadil
• Minoxidil
• Sorbitrate
• Others

Indication

• Hypertension
• Angina
• Heart Failure
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Vasodilators Market Regional Analysis/Insights

The global vasodilators market is analyzed and market size insights and trends are provided by country, type, drugs, indication, route of administration, end user, and distribution channel as referenced above.

The countries covered in the global vasodilators market  report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global vasodilators market because of the strong base of healthcare facilities, the presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having hypertension.

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for cardiac diseases, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.  

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global vasodilators market  also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global vasodilators market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on global the Vasodilators market.

Competitive Landscape and Vasodilators Market Share Analysis

Le paysage concurrentiel du marché des vasodilatateurs fournit des détails par concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des vasodilatateurs.

Certains des principaux acteurs opérant sur le marché des vasodilatateurs sont :

• Sun Pharmaceutical Industries Ltd (Inde).
• Teva Pharmaceutical Industries Ltd (Israël)
• Amneal Pharmaceutical Inc (États-Unis)
• Zydus Cadila (Inde)
• Mylan NV (États-Unis)
• Aurobindo Pharma (Inde)
• Bausch Santé (Canada)
• Hercon Pharmaceuticals, LLC (États-Unis)
• Dr. Reddy's Laboratories Ltd (Inde)

SKU-53544